-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Obinutuzumab in Kidney Disease (Nephropathy)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Obinutuzumab in Kidney Disease (Nephropathy) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Obinutuzumab in Kidney Disease (Nephropathy) Drug Details: Obinutuzumab (Gazyva, Gazyvaro,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Obinutuzumab in Nephrotic Syndrome
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Obinutuzumab in Nephrotic Syndrome report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Obinutuzumab in Nephrotic Syndrome Drug Details: Obinutuzumab (Gazyva, Gazyvaro, Gaziva) is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Obinutuzumab in Relapsed Chronic Lymphocytic Leukemia (CLL)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Obinutuzumab in Relapsed Chronic Lymphocytic Leukemia (CLL) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Obinutuzumab in Relapsed Chronic Lymphocytic Leukemia (CLL) Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Obinutuzumab in Refractory Chronic Lymphocytic Leukemia (CLL)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Obinutuzumab in Refractory Chronic Lymphocytic Leukemia (CLL) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Obinutuzumab in Refractory Chronic Lymphocytic Leukemia (CLL) Drug...
-
Consumer Insights
NewChina Apparel Consumer Insights – Who Shops, What do they Shop, How do they Shop and Why do they Shop
China Apparel Consumer Insights Report Overview Most Chinese consumers are optimistic about the country's economic outlook for the next six months, with nearly 50% of consumers expecting overall economic improvement and around the same percentage anticipating improvement in their finances. As a result, more Chinese consumers are planning to spend more on clothing & accessories, and footwear, especially among females, driven by their inclination toward following trends. There is a clear preference for online shopping among Chinese apparel shoppers, propelled...
-
Company Insights
NewAffirm – Competitor Profile
Founded in 2012, Affirm was one of the earliest buy now pay later (BNPL) startups enabling consumers to pay for goods and services in installments. Its BNPL service was initially available online but was later extended to include in-store purchases. Founded in 2012, Affirm was one of the earliest buy now pay later (BNPL) startups enabling consumers to pay for goods and services in installments. Its BNPL service was initially available online but was later extended to include in-store purchases....
-
Consumer Insights
NewUnited States (US) Apparel Consumer Insights – Who Shops, What do they Shop, How do they Shop and Why do they Shop
US Apparel Consumer Insights Report Overview More than 77% of US consumers bought apparel from physical stores in 2023. However, many consumers plan to cut back on their clothing and accessories spend over the next six months. Inflation is expected to ease in 2024, however, this has not reassured consumers about the outlook for the US economy in the next six months. The ‘US Apparel Consumer Insights Report’ provides detailed insights into consumer sentiment among apparel shoppers in the US....
-
Analyst Opinions
NewGastronomy Travel – Key Trends and Market Analysis by Destinations, Challenges and Opportunities, 2024 Update
Gastronomy Travel Market Report Overview Gastronomy tourism is a growing segment of the travel industry. It involves an individual’s exploration of local cuisine and gastronomy as a part of their overall travel experience. A country’s local cuisine reflects the culture’s eating habits and is one of the simplest ways to learn more about its history, culture, and people. Gastro-tourism extends beyond the food that is eaten. It delves into how, where when, and the reason behind eating a specific food....
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Meningococcal Polysaccharide [serotypes A, C, W-135, Y] Vaccine in Neisseria meningitidis Infections
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Meningococcal Polysaccharide [serotypes A, C, W-135, Y] Vaccine in Neisseria meningitidis Infections report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Meningococcal Polysaccharide [serotypes...
-
Case Studies
NewGroup Travel – Case Study
Group Travel Report Overview Group travel refers to any organized, multi-day trip that you pre-book and on which you meet a group of other travelers who booked the same trip. These groups can range in size from a few people to full coach buses of 50 or more travelers. These groups will often include a trip leader, and pre-planned activities, and will have most lodging and meals organized. The group travel case study provides an overview of the increasing interest...